Tuesday, 8 June 2021

Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense


By BY REBECCA ROBBINS AND PAM BELLUCK from NYT Business https://www.nytimes.com/2021/06/08/business/aducanumab-alzheimers-cost.html?partner=IFTTT
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)